Clinical Trial

Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial

Study acronym: CARA-VT RCT
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study compares two arms - the current standard of care catheter ablation for Ventricular Tachycardia compared to stereotactic radiotherapy to non-invasively ablate ventricular tachycardia using a novel non-invasive ECG based body surface mapping technology. This allows investigators to identify ventricular tachycardia circuits to target for subsequent radio ablation. To summarize, the current standard of care invasive catheter ablation to the non-invasive radio ablation.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-09-07; most recent amendment 2025-11-17.
Status change: Not Yet Recruiting → Recruiting 2022-12-07
Trial Details
NCT Number NCT05047198
Lead Sponsor Ottawa Heart Institute Research Corporation
Conditions Ventricular Tachycardia
Enrollment 244 participants
Start Date 2022-12-06
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-11-20